首站-论文投稿智能助手
典型文献
Evaluation of IFIT3 and ORM1 as Biomarkers for Discriminating Active Tuberculosis from Latent Infection
文献摘要:
Objective:Current commercially available immunological tests cannot be used for discriminating active tuberculosis(TB)from latent TB infection.To evaluate the value of biomarker candidates in the diagnosis of active TB,this study aimed to identify differentially expressed genes in peripheral blood mononuclear cells(PBMCs)between patients with active TB and individuals with latent TB infection by transcriptome sequencing.Methods:The differentially expressed genes in unstimulated PBMCs and in Mycobacterium tuberculosis(Mtb)antigen-stimulated PBMCs from patients with active TB and individuals with latent TB infection were identified by transcriptome sequencing.Selected candidate genes were evaluated in cohorts consisting of 110 patients with TB,30 individuals with latent TB infections,and 50 healthy controls by quantitative real-time RT-PCR.Receiver operating characteristic(ROC)curve analysis was performed to calculate the diagnostic value of the biomarker candidates.Results:Among the differentially expressed genes in PBMCs without Mtb antigen stimulation,interferon-induced protein with tetratricopeptide repeats 3(IFIT3)had the highest area under curve(AUC)value(0.918,95%CI:0.852-0.984,P<0.0001)in discriminating patients with active TB from individuals with latent TB infection,with a sensitivity of 91.86%and a specificity of 84.00%.In Mtb antigen-stimulated PBMCs,orosomucoid 1(ORM1)had a high AUC value(0.833,95%CI:0.752-0.915,P<0.0001),with a sensitivity of 81.94%and a specificity of 70.00%.Conclusion:IFIT3 and ORM1 might be potential biomarkers for discriminating active TB from latent TB infection.
文献关键词:
作者姓名:
Bing-fen YANG;Fei ZHAI;Shan YU;Hong-juan AN;Zhi-hong CAO;Yan-hua LIU;Ruo WANG;Xiao-xing CHENG
作者机构:
Tuberculosis Prevention and Control Key Laboratory,Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment,Institute of Senior Department of Tuberculosis,the Eighth Medical Center of Chinese PLA General Hospital,Beijing 100091,China;Fourth Division,Senior Department of Tuberculosis,the Eighth Medical Center of PLA General Hospital,Beijing 100091,China;Department of Tuberculosis Prevention and Control,Senior Department of Tuberculosis,the Eighth Medical Center of PLA General Hospital,Beijing 100091,China
引用格式:
[1]Bing-fen YANG;Fei ZHAI;Shan YU;Hong-juan AN;Zhi-hong CAO;Yan-hua LIU;Ruo WANG;Xiao-xing CHENG-.Evaluation of IFIT3 and ORM1 as Biomarkers for Discriminating Active Tuberculosis from Latent Infection)[J].当代医学科学(英文),2022(06):1201-1212
A类:
ORM1,Discriminating,orosomucoid
B类:
Evaluation,IFIT3,Biomarkers,Active,Tuberculosis,from,Latent,Infection,Objective,Current,commercially,available,immunological,tests,cannot,used,discriminating,active,tuberculosis,TB,latent,To,value,candidates,diagnosis,this,study,aimed,identify,differentially,expressed,genes,peripheral,blood,mononuclear,cells,PBMCs,between,patients,individuals,by,transcriptome,sequencing,Methods,unstimulated,Mycobacterium,Mtb,antigen,were,identified,Selected,evaluated,cohorts,consisting,infections,healthy,controls,quantitative,real,Receiver,operating,characteristic,curve,analysis,was,performed,calculate,diagnostic,Results,Among,without,stimulation,interferon,induced,protein,tetratricopeptide,repeats,had,highest,area,under,sensitivity,specificity,Conclusion,might,potential,biomarkers
AB值:
0.440745
相似文献
The putative NAD(P)H Nitroreductase, Rv3131, is the Probable Activating Enzyme for Metronidazole in Mycobacterium Tuberculosis
DONG Wen Zhu;SHI Jin;CHU Ping;LIU Rong Mei;WEN Shu An;ZHANG Ting Ting;PANG Yu;LU Jie-Department of Infectious Diseases,The First People's Hospital of Ziyang,Ziyang 641300,Sichuan,China;Department of Bacteriology and Immunology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute,Beijing 101149,China;Department of Tuberculosis,Beijing Chest Hospital,Capital Medical University,Beijing 101149,China;Beijing Key Laboratory for Pediatric Diseases of Otolaryngology,Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, Beijing Pediatric Research Institute, Beijing Children's Hospital,Capital Medical University, National Center for Children's Health, Beijing 101149, China
3- to 24-month Follow-up on COVID-19 with Pulmonary Tuberculosis Survivors after Discharge: Results from a Prospective, Multicenter Study
WANG Jing Ya;ZONG Xing Yu;WU Gui Hui;QI Yuan Lin;LI Hui Zhen;JI Xin Yu;TONG Lin;ZHANG Lei;YANG Ming Bo;YANG Pu Ye;LI Ji Ke;XIAO Fu Rong;ZHANG Lin Song;HU Yun Hong;LIU Hong De;XU Shou Fang;SUN Sheng;WU Wei;MAO Ya;LI Min Qing;HOU Hao Hua;GONG Zhao Yuan;GUO Yang;JIAO Li Wen;QIN Jin;WANG Ding Yi;WANG Fang;GUAN Li;LIN Gang;MA Yan;WANG Yan Ping;SHI Nan Nan-Community Health Service Management Center,Dongcheng District,Beijing 100700,China;Institute of BasicResearch in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Public Health Clinical Center of Chengdu,Chengdu 610066,Sichuan,China;Yiyuan TCM Hospital,Zibo 256199,Shandong,China;Institute of Information on Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Xi'an Eighth Hospital,Xi'an 710000,Shaanxi,China;Harbin Infectious Disease Hospital,Harbin 150000,Heilongjiang,China;Hospital(T.C.M)Affiliated to Southwest Medical University,Luzhou 646000,Sichuan,China;Xingtai Hospital of Chinese Medicine,Xingtai 054000,Hebei,China;Shijiazhuang Fifth Hospital,Shijiazhuang 050000,Hebei,China;Jiamusi Infectious Disease Hospital,Jiamusi 154000,Heilongjiang,China;Chengde Hospital of Traditional Chinese Medicine,Chengde 067040,Hebei,China;Hanzhong Central Hospital,Hanzhong 723000,Shaanxi,China;Ankang Hospital of Traditional Chinese Medicine,Ankang 725000,Shaanxi,China;Department of Traditional Chinese medicine,Dazhou Central Hospital,Dazhou 635000,Sichuan,China;China National Medicines Corporation Ltd,Beijing 100077,China;Beijing University of Chinese Medicine,Beijing 101121,China;Infectious Disease Hospital of Heilongjiang Province,Harbin 150030,Heilongjiang,China
Clinical Features and Corrected Factors with Neurosyphilis in HIV/Syphilis Co-Infected Patients Based on Stage of Syphilis
Wang Yuan-Yuan;Shi Mei;Guan Zhi-Fang;Zhang Lei;Gu Xin;Lu Hai-Kong;Qi Teng-Fei;Ni Li-Yan;Wu Juan;Zhao Wei;Peng Rui-Rui;Zhu Lin;Zhou Ping-Yu-Sexually Transmitted Disease Institute, Shanghai Skin Disease Hospital, Clinical School of Anhui Medical University, Shanghai 200050, China;Sexually Transmitted Disease Institute, Shanghai Skin Disease Hospital, Tongji University, School of Medicine, Shanghai 200050, China;China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi’an Jiaotong University Health Science Centre, Xi’an, Shaanxi 710049, China;Melbourne Sexual Health Centre, Alfred Health, Melbourne 3800, Australia;Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne 3800, Australia;Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan 450001, China.
Feasibility and Surgical Effect of Annulus Sparing in Consecutive Patients with Tetralogy of Fallot: A Retrospective Cohort Study
Lv Lizhi;Liu Jinyang;Jiang Xianchao;Liu Yang;Tian Yanjin;Cao Hong;Liu Zhimin;Wang Qiang-Center for Pediatric Cardiac Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China;Echocardiography Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China;Arrhythmia, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China;Department of Cardiac Surgery, Yunnan Fuwai Cardiovascular Hospital, Kunming 650102, China
Establishment and Evaluation of a Prediction Model of BLR for Severity in Coronavirus Disease 2019
He Zebao;Rui Fajuan;Yang Hongli;Ge Zhengming;Huang Rui;Ying Lingjun;Zhao Haihong;Wu Chao;Li Jie-Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Taizhou, Zhejiang 317099, China;Department of Infectious Diseases, Enze Hospital, Taizhou Enze Medical Center (Group), Taizhou, Zhejiang 318053, China;Department of Infectious Disease, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong 250021, China;Department of Infectious Disease, Cheeloo College of Medicine, Shandong University, Ji’nan, Shandong 250012, China;Department of Infectious Diseases, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu 210008, China;Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu 210033, China
Highly Prevalent SARS-CoV-2 Antigenemia in COVID-19 Patients
Zhang Wenyan;Liu Wei;Lin Jiawang;Jin Jing;Zhao Kefu;Zhu Liwei;Wang Xiuzhen;Wang Lijie;Tang Renshu;Zhu Yindi;Zhou Wei;You Enqing;Zhang Lei;Liu Xuxiang;Wu Jinju;Chen Lili;Wang Wenjing;Zhang Qiang;Gao Rongbao-Hefei Center for Disease Control and Prevention, Hefei, Anhui Province 230061, China;BIOHIT Healthcare (Hefei) Co., Hefei, Anhui Province 230000, China;The First People’s Hospital of Hefei, Hefei, Anhui Province 230091, China;Anhui Provincial Hospital, Hefei, Anhui Province 231501, China;State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing 102206, China;NHC Key Laboratory of Biosafety, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
A Predictive Nomogram for Predicting Improved Clinical Outcome Probability in Patients with COVID-19 in Zhejiang Province,China
Jiaojiao Xie;Ding Shi;Mingyang Bao;Xiaoyi Hu;Wenrui Wu;Jifang Sheng;Kaijin Xu;Qing Wang;Jingjing Wu;Kaicen Wang;Daiqiong Fang;Yating Li;Lanjuan Li-State Key Laboratory for Diagnosis and Treatment of Infectious Diseases,National Clinical Research Center for Infectious Diseases,Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,The First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,China;State Key Laboratory of Genetic Engineering,Institute of Biostatistics,School of Life Sciences,Fudan University,Shanghai 200433,China;Division of Hepatobiliary and Pancreatic Surgery,Department of Surgery,Key Lab of Combined Multi-organ Transplantation of the Ministry of Health,The First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,China;Division of of Endocrinology and Metabolism,Department of Internal Medicine System,The First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,China
Construction of an Early Warning Model for Ischemic Stroke Recurrence Based on Generalized Estimating Equation
GAO Yang;XIE Yan-ming;WANG Zhi-fei;ZHANG Jing-xiao;WANG Lei;CAI Ye-feng;SHEN Xiao-ming;ZHAO De-xi;XIE Ying-zhen;ZHAO Xing-quan;MENG Fan-xing;YU Hai-qing-Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Dongfang Hospital,Beijing University of Chinese Medicine,Beijing 100078,China;Renmin University of China,Beijing 100872,China;Guangdong Provincial Hospital of Traditional Chinese Medicine,Guangzhou 510120,China;The First Affiliated Hospital of Henan University of Chinese Medicine,Zhengzhou 450000,China;The Affiliated Hospital to Changchun University of Chinese Medicine,Changchun 130021,China;Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 100700,China;Beijing Tiantan Hospital,Capital Medical University,Beijing 100070,China;Taiyuan Hospital of Traditional Chinese Medicine,Taiyuan 030009,China
Pathological Change of Chronic Hepatitis B Patients with Different Tongue Coatings by Circular Multi-omics Integrated Analysis
TANG Yi-shuang;GUO Jian-chun;XU Lin;ZHANG Xiao-na;SHEN Xiao-ping;HAI Ya-mei;MAO Yu-feng;HU Yi-yang;ZHAO Yu-Key Laboratory of Liver and Kidney Diseases,Institute of Liver Diseases,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203 ,China;Department of Integrated Chinese and Western Medicine,Hangzhou Xixi Hospital,Hangzhou 310023 ,China;National Engineering Center for Biochip at Shanghai,Shanghai 201203 ,China;Institute of Clinical Pharmacology,Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203 ,China;Shanghai Key Laboratory of Traditional Chinese Clinical Medicine,Shanghai 201203 ,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。